Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001722760-17-000002
Filing Date
2017-11-22
Accepted
2017-11-22 12:03:09
Documents
1
Effectiveness Date
2017-11-22
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 5889
  Complete submission text file 0001722760-17-000002.txt   6937
Mailing Address 4000 MASON ROAD SUITE 225 SEATTLE WA 98195
Business Address 4000 MASON ROAD SUITE 225 SEATTLE WA 98195 206-384-6228
Phase Genomics, Inc. (Filer) CIK: 0001722760 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-299384 | Film No.: 171219067